Benchmarks for Natural Language Data Mining with LLMs
Chemical Exchange Format Committee
Clinical Trial Environmental Impact
CMC Process Ontology
Data FAIRy Bioassay Annotation
Digital Analytical Methods (with ASM)
IDMP Ontology
In Vitro NAM Data Standards
In Vitro Pharmacology
In Vivo Efficacy Data Standards
Large Language Models in Life Sciences
LLM and NLP Use Case Database
MNMs for Repurposing Non Clinical In Vivo Data
Open Source Instrument Data Converter Repository
Pharma General Ontology Terminology
Pharmacovigilance Systems and Processes Standards
Social Media Real World Evidence
New Ideas
Current Projects
Delivered Projects
AI / ML
Change Management
CSCS
Data Governance
FAIR
Future Labs Evolution
GSRS Community
Microbiome-Mediated Drug Metabolism Database
Quantum Computing
UXLS
Current Communities
Delivered Communities
Collaboration That Delivered
Username or Email Address
Password
Remember Me
Whitepaper
This peer-reviewed paper examines why decentralized clinical trials remain rare in drug development and proposes four practical recommendations to overcome regulatory, technical, and patient-centered barriers to wider adoption of digital health technologies.
The Next Phase of AI in Life Sciences The findings presented in this report reflect the state of thinking across the life sciences sector during the second half of 2025. In a field where technological cycles increasingly compress into months rather than years, it is important to acknowledge the temporal context. The pace of AI advancement continues to accelerate. Organizational capability evolves more gradually. The widening distance between these two curves is central to the conclusions of this report.
This whitepaper summarizes insights from the Pistoia Alliance Change Management Community’s 2025 activities, highlighting why organizational change efforts in pharma and life sciences often stall and outlining practical, human-centered best practices and a roadmap to strengthen and sustain effective change management for digital transformation.
The EQIP initiative offers a standardized way to collect and share essential technical and digital compatibility details between pharma companies and vendors. This white paper highlights current industry gaps, the challenges EQIP solves, and the value it delivers to both sides.
This white paper, a collaboration between the pharmaceutical industry and patient groups, explores what is next for the industry tackling sustainability alongside a challenging healthcare environment.
Published in November 2024
Research
Published in 2019
